The Lipid Lowdown-Potential To Treat Type II Diabetes
April 13, 2016
NEW ENDOGENOUS LIPID WITH ANTI-DIABETIC AND ANTI-INFLAMMATORY EFFECTS
PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes.
The 141 Edition of the Lipid Lowdown is now available! Keep up with the latest news and products at Avanti.